Issue Navigation
-
Review
-
212-224
Qi FH, Wang ZX, Cai PP, Zhao L, Gao JJ, Kokudo N, Li AY, Han JQ, Tang W
Drug Discov Ther. 2013; 7(6):212-224.
DOI: 10.5582/ddt.2013.v7.6.212
-
225-232
Zhao XL, Han JX
Drug Discov Ther. 2013; 7(6):225-232.
DOI: 10.5582/ddt.2013.v7.6.225
-
233-242
HDAC6: Physiological function and its selective inhibitors for cancer treatment.
Yang PH, Zhang L, Zhang YJ, Zhang J, Xu WF
Drug Discov Ther. 2013; 7(6):233-242.
DOI: 10.5582/ddt.2013.v7.6.233
-
243-247
Oxoprothracarcin, a novel pyrrolo[1,4]benzodiazepine antibiotic from marine Streptomyces sp. M10946.
Han Y, Li YY, Shen Y, Li J, Li WJ, Shen YM
Drug Discov Ther. 2013; 7(6):243-247.
DOI: 10.5582/ddt.2013.v7.6.243
-
248-253
Hu CL, Peng XZ, Tang YP, Liu YW
Drug Discov Ther. 2013; 7(6):248-253.
DOI: 10.5582/ddt.2013.v7.6.248
-
254-260
Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus.
Ichinose T, Musyoka TM, Watanabe K, Kobayashi N
Drug Discov Ther. 2013; 7(6):254-260.
DOI: 10.5582/ddt.2013.v7.6.254
-
261-271
Cerebrolysin attenuates cerebral and hepatic injury due to lipopolysaccharide in rats.
Abdel-Salam OME, Omara EA, Mohammed NA, Youness ER, Khadrawy YA, Sleem AA
Drug Discov Ther. 2013; 7(6):261-271.
DOI: 10.5582/ddt.2013.v7.6.261
-
272-274
-
275-278